We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

35 hedge funds and large institutions have $75.6M invested in Tempest Therapeutics in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 3

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

21% more funds holding

Funds holding: 29 → 35 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $85.1M → $75.6M (-$9.48M)

Holders
35
Holders Change
+6
Holders Change %
+20.69%
% of All Funds
1.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
11
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$5.36M
2
JP Morgan Chase
JP Morgan Chase
New York
+$4.22M
3
Franklin Resources
Franklin Resources
California
+$3.69M
4
SM
Sabby Management
Florida
+$1.95M
5
Northern Trust
Northern Trust
Illinois
+$958K

Top Sellers

Rank Fund Capital Flow
1
BCM
BBT Capital Management
Texas
-$1.67M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$191K
3
Bank of America
Bank of America
North Carolina
-$177K
4
Morgan Stanley
Morgan Stanley
New York
-$150K
5
FTUS
Flow Traders U.S.
New York
-$106K
Name Holding Trade Value Shares
Change 		Change in
Stake
AP
26
Appleton Partners
Massachusetts
$144K +$177K +5 New
BA
27
BlackRock Advisors
Delaware
$140K +$142K +4 +400%
Charles Schwab
28
Charles Schwab
California
$128K – – –
TA
29
Teachers Advisors
New York
$115K – – –
NFA
30
Nationwide Fund Advisors
Ohio
$70K +$35.5K +1 +100%
AIG
31
American International Group
New York
$59.6K +$71K +2 New
BG
32
BlackRock Group
United Kingdom
$31K +$35.5K +1 New
U
33
UBS
Switzerland
$28K – – –
BJ
34
BlackRock Japan
Japan
$24K +$35.5K +1 New
SO
35
STRS Ohio
Ohio
$12K -$35.5K -1 Closed
AllianceBernstein
36
AllianceBernstein
Tennessee
$6K – – –
Ameriprise
37
Ameriprise
Minnesota
$6K – – –
Barclays
38
Barclays
United Kingdom
$6K – – –
Bank of America
39
Bank of America
North Carolina
$2K -$177K -5 Closed
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$76 – – –
Susquehanna International Group
41
Susquehanna International Group
Pennsylvania
– -$191K -5 Closed
Morgan Stanley
42
Morgan Stanley
New York
– -$150K -4 Closed
1
2

TPST Hedge Fund Activity: Q3 2013 in Review

35 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q3 2013, worth a combined $75.6M — down 11% from $85.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new TPST positions and 4 closed out — a net gain of 7 holders — while 11 added to existing stakes and 3 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $5.36M. The largest seller was BBT Capital Management, cutting an estimated $1.67M.

  • 35 institutional investors held Tempest Therapeutics (TPST) as of Q3 2013, up from 29 in Q2 2013.
  • Funds reported $75.6M of Tempest Therapeutics stock for Q3 2013, down 11% quarter-over-quarter.
  • 11 funds opened new Tempest Therapeutics positions in Q3 2013 and 4 closed out, a net change of +7 holders.
  • The largest Tempest Therapeutics buyer in Q3 2013 was Janus Henderson Investors US, an estimated $5.36M added.
  • The largest Tempest Therapeutics seller in Q3 2013 was BBT Capital Management, an estimated $1.67M sold.

Based on aggregated 13F filings for Q3 2013.